No abstract available
MeSH terms
-
Adult
-
Chronic Disease
-
Female
-
Fibrosis / epidemiology*
-
Fibrosis / mortality
-
Global Burden of Disease
-
Hepatitis B / epidemiology*
-
Hepatitis B Surface Antigens / immunology
-
Hepatitis B virus / isolation & purification
-
Hepatitis D / complications
-
Hepatitis D / drug therapy
-
Hepatitis D / epidemiology*
-
Hepatitis D / mortality
-
Hepatitis Delta Virus / immunology
-
Hepatitis Delta Virus / isolation & purification*
-
Humans
-
Incidence
-
Interferon-alpha / economics
-
Interferon-alpha / therapeutic use
-
Lipopeptides / therapeutic use
-
Liver Diseases / epidemiology
-
Liver Diseases / immunology
-
Liver Diseases / virology*
-
Male
-
Middle Aged
-
Piperidines / therapeutic use
-
Prevalence
-
Pyridines / therapeutic use
-
Risk Factors
-
Superinfection / complications
-
Uzbekistan / epidemiology
Substances
-
Hepatitis B Surface Antigens
-
Interferon-alpha
-
Lipopeptides
-
Piperidines
-
Pyridines
-
myrcludex-B
-
lonafarnib